We had the chance to go down under last month to visit with our customers and speak at the Future Forum at AusBioTech in Australia. AusBiotech is Australia’s life sciences organization, working on behalf of members for more than 30 years to provide representation and services to promote the global growth of the Australian life sciences industry.
Deep 6 AI’s VP of Business Development, Eric Gildenhuys, joined the Future Forum panel, which looked at what is on the horizon for the life sciences industry in terms of technologies, trends, and the issues they create. The panel covered a lot of ground, from changing thoughts about aging to the rise of genomic-related therapies to the increasing concerns about patient privacy.
Deep 6 AI VP of Business Development Eric Gildenhuys (center) participating in the Future Forum panel at AusBiotech 2019
From the dozens of meetings and conversations we had on the trip, we’re confident that AI will play a meaningful role in the future of life sciences and clinical trials.
Our software allows life sciences companies to assess protocol feasibility and conduct site selection in real time — shortcutting a process that takes months and millions of dollars. Interested in seeing it for yourself? Schedule a demo with our team!